| Trial ID: | L4316 |
| Source ID: | NCT04233658
|
| Associated Drug: |
Placebo
|
| Title: |
Cynara Scolymus Extract for Treatment of Diabetes Mellitus Type 2
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Placebo|DRUG: Cynara Scolymus
|
| Outcome Measures: |
Primary: Change of HbA1c-level from baseline to week 12, 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Stefan Fischli
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2020-05
|
| Completion Date: |
2022-12
|
| Results First Posted: |
|
| Last Update Posted: |
2020-01-22
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT04233658
|
